BL vs CLBT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and the absence of an Altman Z-Score prevents a full distress risk assessment. Despite strong gross margins and a history of consistent earnings surprises, the company faces significant headwinds including negative earnings growth, high leverage, and deteriorating profitability. Valuation metrics are stretched relative to fundamentals, with a P/E of 48.25 and a Graham Number of just $11.64, implying the stock is trading at a substantial premium. Persistent insider selling and weak technical sentiment further reinforce caution.
CLBT shows bullish fundamentals based on deterministic rules. Financial strength is strong (F-Score 7/9). Key strengths include strong valuation and growth metrics. Price trades at a 370.1% premium to fair value estimate ($3.01), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
BL vs CLBT: Head-to-Head Comparison
This page compares BlackLine, Inc. (BL) and Cellebrite DI Ltd. (CLBT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.